Related Experiment Videos
Guillain-Barré syndrome
Dana L Newswanger1, Charles R Warren
1National Naval Medical Center, Family Practice Dept, Bethesda, Maryland 20889, USA. DLNewswanger@Bethesda.med.navy.mil
American Family Physician
|June 1, 2004
Summary
Guillain-Barré syndrome (GBS) is an autoimmune disorder affecting nerves, often triggered by infection. While most patients recover, severe cases may involve paralysis and require treatments like immunoglobulin therapy or plasmapheresis.
Area of Science:
- Neurology
- Immunology
- Autoimmune Diseases
Background:
- Guillain-Barré syndrome (GBS) encompasses autoimmune conditions with demyelinating and axonal nerve damage.
- It presents as progressive paralysis, typically reaching a plateau.
- Most GBS cases resolve significantly, but mortality is linked to dysautonomia and respiratory failure.
Purpose of the Study:
- To differentiate the heterogeneous subtypes of Guillain-Barré syndrome.
- To outline the clinical presentation, pathophysiology, and management strategies for GBS.
Main Methods:
- Nerve conduction studies are crucial for distinguishing GBS subtypes.
- Clinical observation of disease progression, plateau, and resolution phases.
- Review of common antecedent infections triggering the autoimmune response.
Main Results:
- GBS subtypes vary, impacting prognosis and treatment.
- Antecedent infections are common triggers due to pathogen-nerve cross-reactivity.
- Complete or near-complete resolution occurs in most patients.
Conclusions:
- Prompt diagnosis and subtype differentiation via nerve conduction studies are vital.
- Management includes supportive care, respiratory support, and immunotherapy (IVIg or plasmapheresis).
- Neurological consultation is recommended for optimal patient outcomes.